- Report
- October 2024
- 199 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 194 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- October 2024
- 180 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 180 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 189 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- December 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- March 2025
- 92 Pages
Global
From €5316EUR$5,600USD£4,484GBP
- Clinical Trials
- May 2024
- 80 Pages
Global
From €1899EUR$2,000USD£1,602GBP
- Report
- January 2025
- 250 Pages
Global
From €4746EUR$4,999USD£4,003GBP
- Report
- December 2024
Global, Europe, United States, ... Global, Europe, United States, Japan
From €17563EUR$18,500USD£14,814GBP
- Report
- February 2025
Global, Europe, United States, ... Global, Europe, United States, Japan
From €3560EUR$3,750USD£3,003GBP
- Report
- December 2024
North America, Mexico, ... North America, Mexico, Canada
From €9019EUR$9,500USD£7,607GBP
- Report
- December 2024
United States
From €2373EUR$2,500USD£2,002GBP
- Report
- February 2025
Middle East
From €4272EUR$4,500USD£3,603GBP
- Report
- February 2025
North America, Mexico, ... North America, Mexico, Canada
From €2326EUR$2,450USD£1,962GBP
- Report
- February 2025
France, Germany, ... France, Germany, Italy, Spain, United Kingdom, Europe
From €2706EUR$2,850USD£2,282GBP
- Report
- February 2025
United States
From €1377EUR$1,450USD£1,161GBP
- Report
- September 2021
- 40 Pages
China
From €2468EUR$2,600USD£2,082GBP
- Report
- March 2024
- 30 Pages
Global
From €2611EUR$2,750USD£2,202GBP
- Clinical Trials
- January 2024
- 120 Pages
Global
From €1899EUR$2,000USD£1,602GBP

Thrombin is a hematological drug used to treat bleeding disorders. It is a naturally occurring enzyme in the body that helps to form blood clots. Thrombin is used to treat a variety of conditions, including hemophilia, deep vein thrombosis, and pulmonary embolism. It is also used to help control bleeding during surgery. Thrombin is available in both injectable and topical forms. The injectable form is used to treat more serious conditions, while the topical form is used to treat minor cuts and scrapes.
The thrombin market is highly competitive, with a number of companies offering products. Some of the major players in the market include Pfizer, Novo Nordisk, Bayer, and Sanofi. Other companies in the market include CSL Behring, Grifols, and Kedrion Biopharma. Show Less Read more